Lupin Limited — Board Meeting, 06-08-2026: Outcome of Board Meeting
06-08-2026 | 09:53 pm
06-08-2026 | 09:53 pm
Lupin's board met, approving Q1 consolidated results. Revenue reached ₹8,276.89 Cr, with profit after tax at ₹1,416.98 Cr. EPS was ₹30.95. A significant update is the acquisition of VISUfarma B.V. for ₹2,090.27 Cr, expanding their ophthalmology presence.
No comments yet. Be the first to comment!
